Cargando…

TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia

PURPOSE: The presence of diffuse anaplasia in Wilms tumours (DAWT) is associated with TP53 mutations and poor outcome. As patients receive intensified treatment, we sought to identify whether TP53 mutational status confers additional prognostic information. PATIENTS AND METHODS: We studied 40 patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maschietto, Mariana, Williams, Richard D., Chagtai, Tasnim, Popov, Sergey D., Sebire, Neil J., Vujanic, Gordan, Perlman, Elizabeth, Anderson, James R., Grundy, Paul, Dome, Jeffrey S., Pritchard-Jones, Kathy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196953/ https://www.ncbi.nlm.nih.gov/pubmed/25313908 http://dx.doi.org/10.1371/journal.pone.0109924

Ejemplares similares

Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour
por: Charlton, Jocelyn, et al.
Publicado: (2015)

Multiple mechanisms of MYCN dysregulation in Wilms tumour
por: Williams, Richard D., et al.
Publicado: (2015)

TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia
por: Wegert, Jenny, et al.
Publicado: (2017)

Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors()()
por: Treger, Taryn D., et al.
Publicado: (2018)

Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications
por: Cresswell, George D., et al.
Publicado: (2016)

Stratification of Wilms tumor by genetic and epigenetic analysis
por: Scott, Richard H., et al.
Publicado: (2012)

Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood
por: Charlton, Jocelyn, et al.
Publicado: (2014)

miRNA Profiles as a Predictor of Chemoresponsiveness in Wilms’ Tumor Blastema
por: Watson, Jenny A., et al.
Publicado: (2013)

Androgen and Anaplasia
por: Huggins, Charles
Publicado: (1947)

Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study
por: Chagtai, Tasnim, et al.
Publicado: (2016)

The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol
por: Vujanić, Gordan M., et al.
Publicado: (2018)

Publisher Correction: The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol
por: Vujanić, Gordan M., et al.
Publicado: (2019)

Comprehensive bioinformatics analysis of the TP53 signaling pathway in Wilms’ tumor
por: He, Changjing, et al.
Publicado: (2020)

The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study
por: Mitchell, C, et al.
Publicado: (2000)

The IGF signalling pathway in Wilms tumours - A report from the ENCCA Renal Tumours Biology-driven drug development workshop
por: Maschietto, Mariana, et al.
Publicado: (2014)

Erratum to comprehensive bioinformatics analysis of the TP53 signaling pathway in Wilms’ tumor
por: He, Changjing, et al.
Publicado: (2021)

Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
por: Grundy, R. G., et al.
Publicado: (1998)

A Pathogenic Mosaic TP53 Mutation in Two Germ Layers Detected by Next Generation Sequencing
por: Behjati, Sam, et al.
Publicado: (2014)

FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia
por: Ballester, Leomar Y., et al.
Publicado: (2018)

Bilateral Wilms tumour: a review of clinical and molecular features
por: Charlton, Jocelyn, et al.
Publicado: (2017)

Primary intramedullary spinal cord pilocytic astrocytoma with anaplasia in an adult: illustrative case
por: Kawasaki, Toshinari, et al.
Publicado: (2022)

A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.
por: Varley, J. M., et al.
Publicado: (1998)

The yin and yang of kidney development and Wilms’ tumors
por: Hohenstein, Peter, et al.
Publicado: (2015)

Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors
por: Krepischi, A. C. V., et al.
Publicado: (2016)

Association between TP53 gene Arg72Pro polymorphism and Wilms’ tumor risk in a Chinese population
por: Fu, Wen, et al.
Publicado: (2017)

The association of miR34b/c and TP53 gene polymorphisms with Wilms tumor risk in Chinese children
por: Wang, Juxiang, et al.
Publicado: (2020)

International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study
por: de Aguirre-Neto, Joaquim Caetano, et al.
Publicado: (2022)

Wilms' Tumour
por: Pearson, D.
Publicado: (1976)

Some Attempts at Human Anaplasia by Means of Mucous Grafts from the Cheeks and Tongues of Rabbits and Oxen
por: De L’aulnoit, Houze
Publicado: (1873)

Gain of Chromosome 6p Correlates with Severe Anaplasia, Cellular Hyperchromasia, and Extraocular Spread of Retinoblastoma
por: Stålhammar, Gustav, et al.
Publicado: (2021)

Glutathione and Its Metabolic Enzymes in Gliomal Tumor Tissue and the Peritumoral Zone at Different Degrees of Anaplasia
por: Obukhova, Larisa, et al.
Publicado: (2022)

Lin28 sustains early renal progenitors and induces Wilms tumor
por: Urbach, Achia, et al.
Publicado: (2014)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30‐year SIOP‐RTSG experience
por: Hol, Janna A., et al.
Publicado: (2020)

Evidence for a delay in diagnosis of Wilms’ tumour in the UK compared with Germany: implications for primary care for children
por: Pritchard-Jones, Kathy, et al.
Publicado: (2016)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

Sertoli-Leydig Cell Tumor of Ovary: A Rare Case Report with Heterologous Elements and Focal Marked Anaplasia
por: Gautam, Parul, et al.
Publicado: (2019)

TP53 rs1042522 C>G polymorphism and Wilms tumor susceptibility in Chinese children: a four-center case–control study
por: Liu, Peng, et al.
Publicado: (2019)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v0dbspvt9hqigdvv07s3jpajbo